Celiac disease in adults: New aspects;La maladie cœliaque de l'adulte: Aspects nouveaux

Revue de Medecine Interne

Volumn 25, Issue 1, 2004, Pages 22-34

  Lepers, S ^a   Couignoux, S ^a   Colombel, J F ^a   Dubucquoi, S ^a  

^a UNIV LILLE   (France)

Author keywords

Adult; Celiac disease; Epidemiology; Pathogenesis; Tissue transglutaminase

Indexed keywords

HLA ANTIGEN CLASS 2;

ABSTINENCE; ATROPHY; BARLEY; CELIAC DISEASE; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTESTINE MUCOSA; MALABSORPTION; PATHOGENESIS; PREVALENCE; REMISSION; REVIEW; RYE; SCREENING TEST; SEROLOGY; WHEAT; ADULT; BLOOD; DIET THERAPY;

ADULT; CELIAC DISEASE; HUMANS;

EID: 1242296254     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2003.10.001     Document Type: Article

References (95)

1. Bode S., Gudmand-Hoyer E. Incidence and prevalence of adult coeliac disease within a defined geographic area in Denmark. Scand J Gastroenterol. 31:1996;694-699.
2. Midhagen G., Jarnerot G., Kraaz W. Adult coeliac disease within a defined geographic area in Sweden. A study of prevalence and associated diseases. Scand J Gastroenterol. 23:1988;1000-1004.
3. Jansen T., Mulder C., Karssen P. Epidemiological survey of Dutch celiac disease society: an update 1992. Eur J Gastroenterol Hepatol. 5:1993.
4. Unsworth D.J., Brown D.L. Serological screening suggests that adult coeliac disease is underdiagnosed in the UK and increases the incidence by up to 12%. Gut. 35:1994;61-64.
5. Volta U., Bellentani S., Bianchi F.B., Brandi G., De Franceschi L., Miglioli L., et al. High prevalence of celiac disease in Italian general population. Dig Dis Sci. 46:2001;1500-1505.
6. Not T., Horvath K., Hill I.D., Partanen J., Hammed A., Magazzu G., et al. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol. 33:1998;494-498.
7. Couignoux S., Ocmant A., Cottel D., Mascart F., Geboes K., Cortot A., et al. Prévalence de la maladie cœliaque de l'adulte en population générale : premières données dans le Nord de la France. Gastroenterol Clin Biol. 24:2000;125.
8. Johnston S.D., Watson R.G., McMillan S.A., Sloan J., Love A.H. Prevalence of coeliac disease in Northern Ireland. Lancet. 350:1997;1370.
9. West J., Lloyd C., Reader R., Hill P., Holmes G., Khaw K., et al. Prevalence of undiagnosed coeliac disease in the general population of England. Gut. 48:(suppl):2001;A1-A124.
10. Riestra S., Fernandez E., Rodrigo L., Garcia S., Ocio G. Prevalence of Coeliac disease in the general population of northern Spain. Strategies of serologic screening. Scand J Gastroenterol. 35:2000;398-402.
11. Ivarsson A., Persson L.A., Juto P., Peltonen M., Suhr O., Hernell O. High prevalence of undiagnosed coeliac disease in adults: a Swedish population-based study. J Intern Med. 245:1999;63-68.
12. Hovdenak N., Hovlid E., Aksnes L., Fluge G., Erichsen M.M., Eide J. High prevalence of asymptomatic coeliac disease in Norway: a study of blood donors. Eur J Gastroenterol Hepatol. 11:1999;185-187.
13. Sanders D.S., Carter M.J., Hurlstone D.P., Pearce A., Ward A.M., McAlindon M.E., et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet. 358:2001;1504-1508.
14. Howard M.R., Turnbull A.J., Morley P., Hollier P., Webb R., Clarke A. A prospective study of the prevalence of undiagnosed coeliac disease in laboratory defined iron and folate deficiency. J Clin Pathol. 55:2002;754-757.
15. Nuti R., Martini G., Valenti R., Giovani S., Salvadori S., Avanzati A. Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern Med. 250:2001;361-366.
16. McFarlane X.A., Bhalla A.K., Reeves D.E., Morgan L.M., Robertson D.A. Osteoporosis in treated adult coeliac disease. Gut. 36:1995;710-714.
17. Scott E.M., Gaywood I., Scott B.B. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut. 46:(Suppl 1):2000;1-8.
18. Collin P., Salmi J., Hallstrom O., Oksa H., Oksala H., Maki M., et al. High frequency of coeliac disease in adult patients with type-I diabetes. Scand J Gastroenterol. 24:1989;81-84.
19. Counsell C.E., Taha A., Ruddell W.S. Coeliac disease and autoimmune thyroid disease. Gut. 35:1994;844-846.
20. Bushara K.O., Goebel S.U., Shill H., Goldfarb L.G., Hallett M. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol. 49:2001;540-543.
21. Dickey W., McMillan S.A., Callender M.E. High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Clin Gastroenterol. 25:1997;328-329.
22. Bardella M.T., Vecchi M., Conte D., Del Ninno E., Fraquelli M., Pacchetti S., et al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology. 29:1999;654-657.
23. Martinelli P., Troncone R., Paparo F., Torre P., Trapanese E., Fasano C., et al. Coeliac disease and unfavourable outcome of pregnancy. Gut. 46:2000;332-335.
24. Ludvigsson J.F., Ludvigsson J. Coeliac disease in the father affects the newborn. Gut. 49:2001;169-175.
25. Gale L., Wimalaratna H., Brotodiharjo A., Duggan J.M. Down's syndrome is strongly associated with coeliac disease. Gut. 40:1997;492-496.
26. Carnicer J., Farre C., Varea V., Vilar P., Moreno J., Artigas J. Prevalence of coeliac disease in Down's syndrome. Eur J Gastroenterol Hepatol. 13:2001;263-267.
27. Heneghan M.A., Stevens F.M., Cryan E.M., Warner R.H., McCarthy C.F. Celiac sprue and immunodeficiency states: a 25-year review. J Clin Gastroenterol. 25:1997;421-425.
28. Ferguson A., Arranz E., O'Mahony S. Clinical and pathological spectrum of coeliac disease-active, silent, latent, potential. Gut. 34:1993;150-151.
29. Bardella M.T., Trovato C., Quatrini M., Conte D. Mesenteric lymph node cavitation: a rare hallmark of celiac disease. Scand J Gastroenterol. 34:1999;1257-1259.
30. Corrao G., Corazza G.R., Bagnardi V., Brusco G., Ciacci C., Cottone M., et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 358:2001;356-361.
31. Holmes G.K., Prior P., Lane M.R., Pope D., Allan R.N. Malignancy in coeliac disease - effect of a gluten free diet. Gut. 30:1989;333-338.
32. Cellier C., Patey N., Mauvieux L., Jabri B., Delabesse E., Cervoni J.P., et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology. 114:1998;471-481.
33. Dahlqvist A., Lindberg T., Meeuwisse G., Akerman M. Intestinal dipeptidases and disaccharidases in children with malabsorption. Acta Paediatr Scand. 59:1970;621-630.
34. Walker-Smith J., Guandalini S., Schmitz J., Shmerling D., Visakorpi J. Revised criteria for diagnosis of celiac disease: Report of working group of European Society of Pediatric Gastroenterology and Nutrition (ESPGAN). Arch Dis Child. 65:1990;909-911.
35. Seah P.P., Fry L., Rossiter M.A., Hoffbrand A.V., Holborow E.J. Anti-reticulin antibodies in childhood coeliac disease. Lancet. 2:1971;681-682.
36. Boige V., Bouhnik Y., Delchier J.C., Jian R., Matuchansky C., Andre C. Anti-endomysium and anti-reticulin antibodies in adults with celiac disease followed-up in the Paris area. Gastroenterol Clin Biol. 20:1996;931-937.
37. Catassi C., Ratsch I.M., Fabiani E., Rossini M., Bordicchia F., Candela F., et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet. 343:1994;200-203.
38. André C. Anticorps anti-transglutaminase tissulaire. Spectra Biologie. 20:2001;39-43.
39. Farrell R.J., Kelly C.P. Diagnosis of celiac sprue. Am J Gastroenterol. 96:2001;3237-3246.
40. Uibo O., Uibo R., Kleimola V., Jogi T., Maki M. Serum IgA anti-gliadin antibodies in an adult population sample. High prevalence without celiac disease. Dig Dis Sci. 38:1993;2034-2037.
41. Cataldo F., Marino V., Ventura A., Bottaro G., Corazza G.R. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP) and "Club del Tenue" Working Groups on Coeliac Disease. Gut. 42:1998;362-365.
42. Burgin-Wolff A., Gaze H., Hadziselimovic F., Huber H., Lentze M.J., Nussle D., et al. Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child. 66:1991;941-947.
43. Kelly C.P., Feighery C.F., Gallagher R.B., Gibney M.J., Weir D.G. Mucosal and systemic IgA anti-gliadin antibody in celiac disease. Contrasting patterns of response in serum, saliva, and intestinal secretions. Dig Dis Sci. 36:1991;743-751.
44. Chorzelski T.P., Sulej J., Tchorzewska H., Jablonska S., Beutner E.H., Kumar V. IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann N Y Acad Sci. 420:1983;325-334.
45. Ladinser B., Rossipal E., Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut. 35:1994;776-778.
46. Rostami K., Kerckhaert J., Tiemessen R., von Blomberg B.M., Meijer J.W., Mulder C.J. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol. 94:1999;888-894.
47. Tursi A., Brandimarte G., Giorgetti G., Gigliobianco A., Lombardi D., Gasbarrini G. Low prevalence of antigliadin and anti-endomysium antibodies in subclinical/silent celiac disease. Am J Gastroenterol. 96:2001;1507-1510.
48. Dickey W., Hughes D.F., McMillan S.A. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol. 95:2000;712-714.
49. Dieterich W., Ehnis T., Bauer M., Donner P., Volta U., Riecken E.O., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 3:1997;797-801.
50. Dieterich W., Laag E., Schopper H., Volta U., Ferguson A., Gillett H., et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology. 115:1998;1317-1321.
51. Amin M., Eckhardt T., Kapitza S., Fleckenstein B., Jung G., Seissler J., et al. Correlation between tissue transglutaminase antibodies and endomysium antibodies as diagnostic markers of coeliac disease. Clin Chim Acta. 282:1999;219-225.
52. Troncone R., Maurano F., Rossi M., Micillo M., Greco L., Auricchio R., et al. IgA antibodies to tissue transglutaminase: An effective diagnostic test for celiac disease. J Pediatr. 134:1999;166-171.
53. Leon F., Camerero C., Saanchez L., Eiras P., Del Amo A., et al. Limitations of anti-guinea pig liver transglutaminase IgA in screening of celiac disease. Gastroenterology. 120:2001;586-587.
54. Sardy M., Odenthal U., Karpati S., Paulsson M., Smyth N. Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. Clin Chem. 45:1999;2142-2149.
55. Wong R.C., Wilson R.J., Steele R.H., Radford-Smith G., Adelstein S. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol. 55:2002;488-494.
56. Sblattero D., Berti I., Trevisiol C., Marzari R., Tommasini A., Bradbury A., et al. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol. 95:2000;1253-1257.
57. Lepers S., Soula F., Fily S., Fontaine E., Vuye S., Colombel J.F., et al. Relevance of anti-tissue transglutaminase antibodies in coeliac disease diagnosis. Ann Biol Clin (Paris). 61:2003;337-343.
58. Catassi C., Fornaroli F., Fasano A. Celiac disease: From basic immunology to bedside practice. Clin Appl Immunol Rev. 3:2002;61-71.
59. Martini S., Mengozzi G., Aimo G., Giorda L., Pagni R., Guidetti C.S. Comparative evaluation of serologic tests for celiac disease diagnosis and follow-up. Clin Chem. 48:2002;960-963.
60. Gomez J.C., Selvaggio G., Pizarro B., Viola M.J., La Motta G., Smecuol E., et al. Value of a screening algorithm for celiac disease using tissue transglutaminase antibodies as first level in a population-based study. Am J Gastroenterol. 97:2002;2785-2790.
61. Koop I., Ilchmann R., Izzi L., Adragna A., Koop H., Barthelmes H. Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis. Am J Gastroenterol. 95:2000;2009-2014.
62. Kaukinen K., Sulkanen S., Maki M., Collin P. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Hepatol. 14:2002;311-315.
63. Janatuinen E.K., Kemppainen T.A., Julkunen R.J., Kosma V.M., Maki M., Heikkinen M., et al. No harm from five year ingestion of oats in coeliac disease. Gut. 50:2002;332-335.
64. Sollid L.M., Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology. 105:1993;910-922.
65. Polvi A., Arranz E., Fernandez-Arquero M., Collin P., Maki M., Sanz A., et al. HLA-DQ2-negative celiac disease in Finland and Spain. Hum Immunol. 59:1998;169-175.
66. Fodil N., Pellet P., Laloux L., Hauptmann G., Theodorou I., Bahram S. MICA haplotypic diversity. Immunogenetics. 49:1999;557-560.
67. Popat S., Hearle N., Hogberg L., Braegger C.P., O'Donoghue D., Falth-Magnusson K., et al. Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease. Ann Hum Genet. 66:2002;125-137.
68. King A.L., Yiannakou J.Y., Brett P.M., Curtis D., Morris M.A., Dearlove A.M., et al. A genome-wide family-based linkage study of coeliac disease. Ann Hum Genet. 64:2000;479-490.
69. Zhong F., McCombs C.C., Olson J.M., Elston R.C., Stevens F.M., McCarthy C.F., et al. An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland. Nat Genet. 14:1996;329-333.
70. Woolley N., Holopainen P., Ollikainen V., Mustalahti K., Maki M., Kere J., et al. A new locus for coeliac disease mapped to chromosome 15 in a population isolate. Hum Genet. 111:2002;40-45.
71. Lahteenoja H., Maki M., Viander M., Raiha I., Vilja P., Rantala I., et al. Local challenge on oral mucosa with an alpha-gliadin related synthetic peptide in patients with celiac disease. Am J Gastroenterol. 95:2000;2880-2887.
72. Cellier C., Cervoni J.P., Patey N., Leborgne M., Marteau P., Landi B., et al. Gluten-free diet induces regression of T-cell activation in the rectal mucosa of patients with celiac disease. Am J Gastroenterol. 93:1998;1527-1530.
73. Trier J.S. Celiac sprue. N Engl J Med. 325:1991;1709-1719.
74. Jabri B., de Serre N.P., Cellier C., Evans K., Gache C., Carvalho C., et al. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology. 118:2000;867-879.
75. Groh V., Steinle A., Bauer S., Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science. 279:1998;1737-1740.
76. Oberhuber G., Vogelsang H., Stolte M., Muthenthaler S., Kummer A.J., Radaszkiewicz T. Evidence that intestinal intraepithelial lymphocytes are activated cytotoxic T cells in celiac disease but not in giardiasis. Am J Pathol. 148:1996;1351-1357.
77. Halstensen T.S., Brandtzaeg P. Activated T lymphocytes in the celiac lesion: non-proliferative activation (CD25) of CD4+ alpha/beta cells in the lamina propria but proliferation (Ki-67) of alpha/bêta and gamma/delta cells in the epithelium. Eur J Immunol. 23:1993;505-510.
78. Marsh M.N. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology. 102:1992;330-354.
79. Feighery C., Weir D.G., Whelan A., Willoughby R., Youngprapakorn S., Lynch S., et al. Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate? Eur J Gastroenterol Hepatol. 10:1998;919-925.
80. Lundin K.E., Scott H., Hansen T., Paulsen G., Halstensen T.S., Fausa O., et al. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med. 178:1993;187-196.
81. Nilsen E.M., Lundin K.E., Krajci P., Scott H., Sollid L.M., Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut. 37:1995;766-776.
82. Lundin K.E., Scott H., Fausa O., Thorsby E., Sollid L.M. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol. 41:1994;285-291.
83. Martucci S., Corazza G.R. Spreading and focusing of gluten epitopes in celiac disease. Gastroenterology. 122:2002;2072-2075.
84. Vader W., Kooy Y., Van Veelen P., De Ru A., Harris D., Benckhuijsen W., et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology. 122:2002;1729-1737.
85. Sjostrom H., Lundin K.E., Molberg O., Korner R., McAdam S.N., Anthonsen D., et al. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol. 48:1998;111-115.
86. Molberg O., McAdam S., Lundin K.E., Kristiansen C., Arentz-Hansen H., Kett K., et al. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur J Immunol. 31:2001;1317-1323.
87. Bruce S.E., Bjarnason I., Peters T.J. Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Clin Sci (Lond). 68:1985;573-579.
88. Fesus L., Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci. 27:2002;534-539.
89. Seissler J., Wohlrab U., Wuensche C., Scherbaum W.A., Boehm B.O. Autoantibodies from patients with coeliac disease recognize distinct functional domains of the autoantigen tissue transglutaminase. Clin Exp Immunol. 125:2001;216-221.
90. Sollid L.M., Molberg O., McAdam S., Lundin K.E. Autoantibodies in coeliac disease: tissue transglutaminase-guilt by association? Gut. 41:1997;851-852.
91. Maiuri L., Ciacci C., Vacca L., Ricciardelli I., Auricchio S., Quaratino S., et al. IL-15 drives the specific migration of CD94+ and TCR-gammadelta+ intraepithelial lymphocytes in organ cultures of treated celiac patients. Am J Gastroenterol. 96:2001;150-156.
92. Bajaj-Elliott M., Poulsom R., Pender S.L., Wathen N.C., MacDonald T.T. Interactions between stromal cell-derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia. J Clin Invest. 102:1998;1473-1480.
93. Nunes I., Gleizes P.E., Metz C.N., Rifkin D.B. Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol. 136:1997;115-163.
94. Schuppan D., Hahn E.G. Biomedicine. Gluten and the gut-lessons for immune regulation. Science. 297:2002;2218-2220.
95. Kaukinen K., Partanen J., Maki M., Collin P. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol. 97:2002;695-699.